Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting
The relative efficacy of the various classes of antidepressants has not been established. Observational studies in naturalistic settings are important in evaluating treatment outcomes with antidepressants, since controlled clinical trials include only a minority of patients present in clinical pract...
Gespeichert in:
Veröffentlicht in: | Nordic journal of psychiatry 2009, Vol.63 (4), p.347-351 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 351 |
---|---|
container_issue | 4 |
container_start_page | 347 |
container_title | Nordic journal of psychiatry |
container_volume | 63 |
creator | Bukh, Jens Drachmann Jørgensen, Martin Balslev Dam, Henrik Plenge, Per |
description | The relative efficacy of the various classes of antidepressants has not been established. Observational studies in naturalistic settings are important in evaluating treatment outcomes with antidepressants, since controlled clinical trials include only a minority of patients present in clinical practice. This study sought to evaluate in a naturalistic setting the treatment outcomes of dosulepin and venlafaxine for patients with depressive episodes. At the university hospital in Copenhagen, Denmark, between 1998 and early 2001, the first-line treatment for psychiatric inpatients with depression was dosulepin; after that time, venlafaxine was the first-line medication. We compared the treatment outcomes among inpatients during the respective periods. There was no significant difference in the primary outcome parameters between the two groups. A tendency in favour of dosulepin confirmed by a post-hoc analysis suggested that the failure to achieve significant difference was related to a type 2 error. However, missing data and possible confounders related to the different treatment periods weaken the results. This naturalistic study showed a non-significant trend for poorer treatment outcomes (probably because of an underpowered design) after replacing dosulepin with venlafaxine as first-line drug for depression in a naturalistic inpatient setting. |
doi_str_mv | 10.1080/08039480902799099 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmed_primary_19347769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19347769</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-f93ed9661bdd73fdfbb2e1bbbeea4ea0e9a934365343d22bc5fa60b675c1b9fe3</originalsourceid><addsrcrecordid>eNp9UF1LwzAUDaK4Of0Bvkj_QDVp1nZBX2T4BQNf9LncNDcuo0tKkqr792ZsICIM7hfccw6HQ8glo9eMzuhNai6mMypoUQtBhTgiY1bSIp_WRXlMxtt_ngCzETkLYUUp5bwQp2TEBJ_WdSXGpJm7dQ_eBGczp7O4xAxsNAp7jyGkM0OtsY1h-_1E24GGb2O3KJUpF4YOe2OzVJBZiIOHzoRo2ixgjMZ-nJMTDV3Ai_2ekPfHh7f5c754fXqZ3y_yls9ozLXgqERVMalUzbXSUhbIpJSIMEWgKCBZ5lWZhioK2ZYaKiqrumyZFBr5hLCdbutdCB5103uzBr9pGG22YTX_wkqcqx2nH-Qa1S9jn04C3O0Axmrn1_DlfKeaCJvOee3BtiY0_JD-7R_6EqGLyxY8Nis3eJvyOODuB7l0jUE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting</title><source>MEDLINE</source><source>Taylor & Francis Medical Library - CRKN</source><source>Taylor & Francis Journals Complete</source><creator>Bukh, Jens Drachmann ; Jørgensen, Martin Balslev ; Dam, Henrik ; Plenge, Per</creator><creatorcontrib>Bukh, Jens Drachmann ; Jørgensen, Martin Balslev ; Dam, Henrik ; Plenge, Per</creatorcontrib><description>The relative efficacy of the various classes of antidepressants has not been established. Observational studies in naturalistic settings are important in evaluating treatment outcomes with antidepressants, since controlled clinical trials include only a minority of patients present in clinical practice. This study sought to evaluate in a naturalistic setting the treatment outcomes of dosulepin and venlafaxine for patients with depressive episodes. At the university hospital in Copenhagen, Denmark, between 1998 and early 2001, the first-line treatment for psychiatric inpatients with depression was dosulepin; after that time, venlafaxine was the first-line medication. We compared the treatment outcomes among inpatients during the respective periods. There was no significant difference in the primary outcome parameters between the two groups. A tendency in favour of dosulepin confirmed by a post-hoc analysis suggested that the failure to achieve significant difference was related to a type 2 error. However, missing data and possible confounders related to the different treatment periods weaken the results. This naturalistic study showed a non-significant trend for poorer treatment outcomes (probably because of an underpowered design) after replacing dosulepin with venlafaxine as first-line drug for depression in a naturalistic inpatient setting.</description><identifier>ISSN: 0803-9488</identifier><identifier>EISSN: 1502-4725</identifier><identifier>DOI: 10.1080/08039480902799099</identifier><identifier>PMID: 19347769</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Adult ; Antidepressants ; Antidepressive Agents, Second-Generation - adverse effects ; Antidepressive Agents, Second-Generation - pharmacokinetics ; Antidepressive Agents, Second-Generation - therapeutic use ; Antidepressive Agents, Tricyclic - adverse effects ; Antidepressive Agents, Tricyclic - pharmacokinetics ; Antidepressive Agents, Tricyclic - therapeutic use ; Cyclohexanols - adverse effects ; Cyclohexanols - pharmacokinetics ; Cyclohexanols - therapeutic use ; Denmark ; Depressive Disorder, Major - blood ; Depressive Disorder, Major - diagnosis ; Depressive Disorder, Major - drug therapy ; Dosulepin ; Dothiepin - adverse effects ; Dothiepin - pharmacokinetics ; Dothiepin - therapeutic use ; Drug Therapy, Combination ; Effectiveness ; Female ; Humans ; Length of Stay ; Male ; Middle Aged ; Naturalistic ; Retrospective Studies ; Treatment Outcome ; Venlafaxine ; Venlafaxine Hydrochloride</subject><ispartof>Nordic journal of psychiatry, 2009, Vol.63 (4), p.347-351</ispartof><rights>2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c380t-f93ed9661bdd73fdfbb2e1bbbeea4ea0e9a934365343d22bc5fa60b675c1b9fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/08039480902799099$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/08039480902799099$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,780,784,4021,27921,27922,27923,59645,59751,60434,60540,61219,61254,61400,61435</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19347769$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bukh, Jens Drachmann</creatorcontrib><creatorcontrib>Jørgensen, Martin Balslev</creatorcontrib><creatorcontrib>Dam, Henrik</creatorcontrib><creatorcontrib>Plenge, Per</creatorcontrib><title>Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting</title><title>Nordic journal of psychiatry</title><addtitle>Nord J Psychiatry</addtitle><description>The relative efficacy of the various classes of antidepressants has not been established. Observational studies in naturalistic settings are important in evaluating treatment outcomes with antidepressants, since controlled clinical trials include only a minority of patients present in clinical practice. This study sought to evaluate in a naturalistic setting the treatment outcomes of dosulepin and venlafaxine for patients with depressive episodes. At the university hospital in Copenhagen, Denmark, between 1998 and early 2001, the first-line treatment for psychiatric inpatients with depression was dosulepin; after that time, venlafaxine was the first-line medication. We compared the treatment outcomes among inpatients during the respective periods. There was no significant difference in the primary outcome parameters between the two groups. A tendency in favour of dosulepin confirmed by a post-hoc analysis suggested that the failure to achieve significant difference was related to a type 2 error. However, missing data and possible confounders related to the different treatment periods weaken the results. This naturalistic study showed a non-significant trend for poorer treatment outcomes (probably because of an underpowered design) after replacing dosulepin with venlafaxine as first-line drug for depression in a naturalistic inpatient setting.</description><subject>Adult</subject><subject>Antidepressants</subject><subject>Antidepressive Agents, Second-Generation - adverse effects</subject><subject>Antidepressive Agents, Second-Generation - pharmacokinetics</subject><subject>Antidepressive Agents, Second-Generation - therapeutic use</subject><subject>Antidepressive Agents, Tricyclic - adverse effects</subject><subject>Antidepressive Agents, Tricyclic - pharmacokinetics</subject><subject>Antidepressive Agents, Tricyclic - therapeutic use</subject><subject>Cyclohexanols - adverse effects</subject><subject>Cyclohexanols - pharmacokinetics</subject><subject>Cyclohexanols - therapeutic use</subject><subject>Denmark</subject><subject>Depressive Disorder, Major - blood</subject><subject>Depressive Disorder, Major - diagnosis</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>Dosulepin</subject><subject>Dothiepin - adverse effects</subject><subject>Dothiepin - pharmacokinetics</subject><subject>Dothiepin - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Effectiveness</subject><subject>Female</subject><subject>Humans</subject><subject>Length of Stay</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Naturalistic</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Venlafaxine</subject><subject>Venlafaxine Hydrochloride</subject><issn>0803-9488</issn><issn>1502-4725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UF1LwzAUDaK4Of0Bvkj_QDVp1nZBX2T4BQNf9LncNDcuo0tKkqr792ZsICIM7hfccw6HQ8glo9eMzuhNai6mMypoUQtBhTgiY1bSIp_WRXlMxtt_ngCzETkLYUUp5bwQp2TEBJ_WdSXGpJm7dQ_eBGczp7O4xAxsNAp7jyGkM0OtsY1h-_1E24GGb2O3KJUpF4YOe2OzVJBZiIOHzoRo2ixgjMZ-nJMTDV3Ai_2ekPfHh7f5c754fXqZ3y_yls9ozLXgqERVMalUzbXSUhbIpJSIMEWgKCBZ5lWZhioK2ZYaKiqrumyZFBr5hLCdbutdCB5103uzBr9pGG22YTX_wkqcqx2nH-Qa1S9jn04C3O0Axmrn1_DlfKeaCJvOee3BtiY0_JD-7R_6EqGLyxY8Nis3eJvyOODuB7l0jUE</recordid><startdate>2009</startdate><enddate>2009</enddate><creator>Bukh, Jens Drachmann</creator><creator>Jørgensen, Martin Balslev</creator><creator>Dam, Henrik</creator><creator>Plenge, Per</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2009</creationdate><title>Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting</title><author>Bukh, Jens Drachmann ; Jørgensen, Martin Balslev ; Dam, Henrik ; Plenge, Per</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-f93ed9661bdd73fdfbb2e1bbbeea4ea0e9a934365343d22bc5fa60b675c1b9fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Antidepressants</topic><topic>Antidepressive Agents, Second-Generation - adverse effects</topic><topic>Antidepressive Agents, Second-Generation - pharmacokinetics</topic><topic>Antidepressive Agents, Second-Generation - therapeutic use</topic><topic>Antidepressive Agents, Tricyclic - adverse effects</topic><topic>Antidepressive Agents, Tricyclic - pharmacokinetics</topic><topic>Antidepressive Agents, Tricyclic - therapeutic use</topic><topic>Cyclohexanols - adverse effects</topic><topic>Cyclohexanols - pharmacokinetics</topic><topic>Cyclohexanols - therapeutic use</topic><topic>Denmark</topic><topic>Depressive Disorder, Major - blood</topic><topic>Depressive Disorder, Major - diagnosis</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>Dosulepin</topic><topic>Dothiepin - adverse effects</topic><topic>Dothiepin - pharmacokinetics</topic><topic>Dothiepin - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Effectiveness</topic><topic>Female</topic><topic>Humans</topic><topic>Length of Stay</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Naturalistic</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Venlafaxine</topic><topic>Venlafaxine Hydrochloride</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bukh, Jens Drachmann</creatorcontrib><creatorcontrib>Jørgensen, Martin Balslev</creatorcontrib><creatorcontrib>Dam, Henrik</creatorcontrib><creatorcontrib>Plenge, Per</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Nordic journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bukh, Jens Drachmann</au><au>Jørgensen, Martin Balslev</au><au>Dam, Henrik</au><au>Plenge, Per</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting</atitle><jtitle>Nordic journal of psychiatry</jtitle><addtitle>Nord J Psychiatry</addtitle><date>2009</date><risdate>2009</risdate><volume>63</volume><issue>4</issue><spage>347</spage><epage>351</epage><pages>347-351</pages><issn>0803-9488</issn><eissn>1502-4725</eissn><abstract>The relative efficacy of the various classes of antidepressants has not been established. Observational studies in naturalistic settings are important in evaluating treatment outcomes with antidepressants, since controlled clinical trials include only a minority of patients present in clinical practice. This study sought to evaluate in a naturalistic setting the treatment outcomes of dosulepin and venlafaxine for patients with depressive episodes. At the university hospital in Copenhagen, Denmark, between 1998 and early 2001, the first-line treatment for psychiatric inpatients with depression was dosulepin; after that time, venlafaxine was the first-line medication. We compared the treatment outcomes among inpatients during the respective periods. There was no significant difference in the primary outcome parameters between the two groups. A tendency in favour of dosulepin confirmed by a post-hoc analysis suggested that the failure to achieve significant difference was related to a type 2 error. However, missing data and possible confounders related to the different treatment periods weaken the results. This naturalistic study showed a non-significant trend for poorer treatment outcomes (probably because of an underpowered design) after replacing dosulepin with venlafaxine as first-line drug for depression in a naturalistic inpatient setting.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>19347769</pmid><doi>10.1080/08039480902799099</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0803-9488 |
ispartof | Nordic journal of psychiatry, 2009, Vol.63 (4), p.347-351 |
issn | 0803-9488 1502-4725 |
language | eng |
recordid | cdi_pubmed_primary_19347769 |
source | MEDLINE; Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete |
subjects | Adult Antidepressants Antidepressive Agents, Second-Generation - adverse effects Antidepressive Agents, Second-Generation - pharmacokinetics Antidepressive Agents, Second-Generation - therapeutic use Antidepressive Agents, Tricyclic - adverse effects Antidepressive Agents, Tricyclic - pharmacokinetics Antidepressive Agents, Tricyclic - therapeutic use Cyclohexanols - adverse effects Cyclohexanols - pharmacokinetics Cyclohexanols - therapeutic use Denmark Depressive Disorder, Major - blood Depressive Disorder, Major - diagnosis Depressive Disorder, Major - drug therapy Dosulepin Dothiepin - adverse effects Dothiepin - pharmacokinetics Dothiepin - therapeutic use Drug Therapy, Combination Effectiveness Female Humans Length of Stay Male Middle Aged Naturalistic Retrospective Studies Treatment Outcome Venlafaxine Venlafaxine Hydrochloride |
title | Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T05%3A42%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20antidepressant%20effects%20of%20venlafaxine%20and%20dosulepin%20in%20a%20naturalistic%20setting&rft.jtitle=Nordic%20journal%20of%20psychiatry&rft.au=Bukh,%20Jens%20Drachmann&rft.date=2009&rft.volume=63&rft.issue=4&rft.spage=347&rft.epage=351&rft.pages=347-351&rft.issn=0803-9488&rft.eissn=1502-4725&rft_id=info:doi/10.1080/08039480902799099&rft_dat=%3Cpubmed_cross%3E19347769%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19347769&rfr_iscdi=true |